Barry H Dash Insider Trades & Stock Holdings

Director · Elite Pharmaceuticals, Inc. · Latest filing Oct 9, 2026

Barry H Dash, Director at Elite Pharmaceuticals, Inc. has 1 Form 4 trade on file since Oct 9, 2026. Open-market activity: 1 purchase ($25.98K) and 0 sales ($0), net +$25.98K. Latest filing: acquired 100K shares of $ELTP on Oct 9, 2026 at $0.26.

Trades on file

1

Open-market bought

$25.98K

Open-market sold

$0

Net open-market

+$25.98K

Shares held ($ELTP)

3.37M

Latest filing

Oct 9, 2026

Shares held by Barry H Dash

• $ELTP3.37M sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Barry H Dash

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 9, 2026	$ELTP	Buy (Open-market buy)	100K	$0.26	$25.98K	3.37M	+3.06%	-3.8%			Director	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Barry H Dash traded

• $ELTP

Frequently asked questions

Has Barry H Dash been buying or selling stock?

Barry H Dash has 1 open-market purchase and 0 open-market sales on file, net +$25.98K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Barry H Dash's latest insider trade?

acquired 100K shares of $ELTP on Oct 9, 2026 at $0.26.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.